title: Granulocytic sarcoma giant in chronic myeloid leukemia during imatinib mesylate therapy.
authors.forename: Rita de Cássia
authors.initials: Rde C
authors.lastname: Rosário Cavalheiro
authors.forename: Perla
authors.initials: P
authors.lastname: Vicari
authors.forename: Fernanda
authors.initials: F
authors.lastname: Maria Morselli
authors.forename: Larissa Veloso M
authors.initials: LV
authors.lastname: Ommati
authors.forename: Fanny de Oliveira
authors.initials: Fde O
authors.lastname: Frazão Rosa
authors.forename: José Salvador
authors.initials: JS
authors.lastname: Rodrigues Oliveira
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001549:Benzamides; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000097:blood / Q000000981:diagnostic imaging / Q000628:therapy*; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D011859:Radiography; D023981:Sarcoma, Myeloid / Q000000981:diagnostic imaging / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate